title: Postpartum acquired haemophilia: a single centre experience with rituximab.
authors.forename: L
authors.initials: L
authors.lastname: Dedeken
authors.forename: J
authors.initials: J
authors.lastname: St-Louis
authors.forename: C
authors.initials: C
authors.lastname: Demers
authors.forename: C
authors.initials: C
authors.lastname: Meilleur
authors.forename: G E
authors.initials: GE
authors.lastname: Rivard
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D005169:Factor VIII / Q000008:administration & dosage*; D005260:Female; D006467:Hemophilia A / Q000150:complications* / Q000628:therapy; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D006473:Postpartum Hemorrhage / Q000188:drug therapy / Q000209:etiology*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D006490:Hemostatics; D007155:Immunologic Factors; D000069283:Rituximab; D005169:Factor VIII